Klein & Partners AG
Family officeZug · Growth–Late Stage · 2 people tracked
Investment thesis
The firm operates as a family office investing its own capital with discretion, speed and long-term alignment. It pursues direct private market investments, shareholder representation, financing, M&A and strategic development, alongside selected late-stage technology opportunities. A notable emphasis is placed on healthcare innovation, company building and strategic growth initiatives, drawing on the team's combined private equity, transaction and healthcare leadership experience.
Source: firm website, verified Aug 3, 2026.
Team · 2 people
from the firm's websiteA hands-on direct investor and entrepreneur with over 15 years of experience across private equity, private credit, M&A, strategy and value creation. Co-founder of LUCID Partners, formerly a Single Family Office Managing Director and Bain & Company consultant; holds an INSEAD MBA and an LSE MSc.
Brings over a decade of international leadership across healthcare, commercial strategy and business transformation, with senior roles at Bristol Myers Squibb and Johnson & Johnson. Focuses on company building and healthcare innovation; holds an MSc from Imperial College London and a Dr. sc. from ETH Zurich.
Frequently asked questions
- What stage does Klein & Partners AG invest at?
- Klein & Partners AG invests at the Growth, Late Stage stages.
- What is Klein & Partners AG's typical check size?
- Klein & Partners AG typically writes checks of $550K – $5.5M.
- What sectors does Klein & Partners AG focus on?
- Klein & Partners AG focuses on Biotech, Healthtech, Medical Devices, Sector Agnostic.
- Where is Klein & Partners AG located?
- Klein & Partners AG is headquartered in Zug, CH.
Similar investors
B Capital Group is a multistage venture capital firm that invests from seed to late stage, offering value-added support to founders in partnership with management consulting firm BCG.
DCVC (Data Collective) is a deep tech venture capital firm backing entrepreneurs using computational approaches to solve large real-world problems across many industries. It operates six flagship funds plus DCVC Bio, spanning 13 funds to date.
GV, originally launched as Google Ventures in 2009, is an independent venture capital firm with Alphabet as its sole limited partner. It invests from seed to growth stages across technology and life sciences and supports founders with operating partners and access to Google and Alphabet resources.
Khosla Ventures is a venture capital firm known for backing bold, contrarian bets in world-class teams that can reshape entire industries.
Kleiner Perkins is a venture capital firm that partners with entrepreneurs to build technology companies, with a history of backing companies from early stage through IPO.